Not Signed In -
Mometasone Furoate |
Elocon |
Image:Mometasone furoate.png Mometasone furoate Systematic (IUPAC) name 9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15, 16-octahydrocyclopenta[a]phenanthren-3-one Identifiers CAS number 105102-22-5 83919-23-7 as Furoate ATC code D07AC13 D07XC03, R01AD09, R03BA07 PubChem 123620 DrugBank APRD00289 Chemical data Formula C22H28Cl2O4 for Mometasone C27H30O6Cl2 as Furoate Mol. weight 427.361 g/mol Pharmacokinetic data Bioavailability ...
Wikipedia - [full article]
Mometasone Furoate Clinical Trials
- Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM1)
ClinicalTrials.gov Identifier: NCT00381485 - Recruiting
Asthma
- Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073)
ClinicalTrials.gov Identifier: NCT00383552 - Recruiting
Asthma
- Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics
ClinicalTrials.gov Identifier: NCT00383240 - Recruiting
Asthma
- Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)
ClinicalTrials.gov Identifier: NCT00383435 - Recruiting
Chronic Obstructive Pulmonary Disease (COPD)
- Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04230AM2)
ClinicalTrials.gov Identifier: NCT00383721 - Recruiting
Chronic Obstructive Pulmonary Disease (COPD)
- Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139)
ClinicalTrials.gov Identifier: NCT00379288 - Active, not recruiting
Asthma
- Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
Asthma
- Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of QMF Twisthaler (Indacaterol Maleate/Mometasone Furoate)
ClinicalTrials.gov Identifier: NCT00557440 - Recruiting
Asthma
- Study of Mometasone Furoate Nasal Spray on Sleep Disturbances and Daytime Sleepiness in Subjects With Symptoms Caused by Seasonal Allergies(Study P04608) (COMPLETED)
ClinicalTrials.gov Identifier: NCT00358527 - Active, not recruiting
Seasonal Allergic Rhinitis
- A Study of the Equivalent Effectiveness of 400 Mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)
ClinicalTrials.gov Identifier: NCT00521599 - Recruiting
Asthma
- A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)
ClinicalTrials.gov Identifier: NCT00442117 - Recruiting
Asthma
- Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (Study P05155)
ClinicalTrials.gov Identifier: NCT00552032 - Recruiting
Adenoid Hypertrophy
- Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
- Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)
ClinicalTrials.gov Identifier: NCT00552110 - Recruiting
Seasonal Allergic Rhinitis
- Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00418509 - Completed
Healthy
- The Effects of Mometasone Furoate Nasal Spray in Subjects With Mild-Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Associated With Perennial Allergic Rhinitis (Study P04726)
ClinicalTrials.gov Identifier: NCT00359216 - Recruiting
Perennial Allergic Rhinitis; Obstructive Sleep Apnea; Hypopnea Syndrome; Sleep Disorder
- Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 Mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00453063 - Completed
Seasonal Allergic Rhinitis
- Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 Mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00468312 - Completed
Seasonal Allergic Rhinitis
- This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00491504 - Completed
Seasonal Allergic Rhinitis
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
Hayfever; Allergic Rhinitis
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00502775 - Recruiting
Allergic Rhinitis; Hay Fever
- Comparator Study Evaluating Patient Preference Of Fluticasone Furoate Nasal Spray vs. Fluticasone Propionate Nasal Spray
ClinicalTrials.gov Identifier: NCT00539006 - Active, not recruiting
Seasonal Allergic Rhinitis
- Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
ClinicalTrials.gov Identifier: NCT00570492 - Recruiting
Perennial Allergic Rhinitis
- A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
ClinicalTrials.gov Identifier: NCT00461812 - Recruiting
Asthma
Resources
- Elocon (Drug Digest)
- Mometasone Furoate (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
